Journal Mobile Options
Table of Contents
Vol. 26, No. 2, 2006
Issue release date: February 2006
Neuroepidemiology 2006;26:61–67

Odor Identification and Decline in Different Cognitive Domains in Old Age

Wilson R.S. · Arnold S.E. · Tang Y. · Bennett D.A.
aRush Alzheimer’s Disease Center, bRush Institute for Healthy Aging, Departments of cNeurological Sciences, dBehavioral Sciences, eInternal Medicine, Rush University Medical Center, Chicago, Ill., and the fCenter for Neurobiology and Behavior, University of Pennsylvania, Philadelphia, Pa., USA

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The authors examined the association of odor identification with rate of decline in different cognitive systems. Participants are 481 older persons from the Rush Memory and Aging Project. At baseline, the Brief Smell Identification Test was administered. At annual intervals for up to 3 years, a battery of 19 cognitive tests was administered from which previously established composite measures of 5 cognitive domains were derived. In mixed-effects models adjusted for age, sex, and education, lower odor identification score was associated with lower function at baseline in each cognitive domain. Lower score was also associated with more rapid decline in perceptual speed (estimate = 0.015, SE = 0.006, p = 0.013) and episodic memory (estimate = 0.012, SE = 0.006, p = 0.030) but not with rate of decline in semantic memory, working memory, or visuospatial ability. Thus, on average, a person with a low odor identification score (6, 10th percentile) declined more than twice as rapidly in perceptual speed and episodic memory as a person with a high score (11, 90th percentile). Results were unchanged in subsequent analyses that controlled for cigarette smoking or clinically diagnosed stroke. The results indicate that impaired odor identification in old age is associated with impaired global cognition and more rapid decline in perceptual processing speed and episodic memory.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Lehrner JP, Gluck J, Laska M: Odor identification, consistency of label use, olfactory threshold and their relationship to odor memory over the human lifespan. Chem Senses 1999;24:337–346.
  2. Murphy C, Schubert CR, Cruisckshanks KJ, Klein BEK, Klein R, Nondahl DM: Prevalence of olfactory impairment in older adults. JAMA 2002;288:2307–2312.
  3. Russell MJ, Cummings BF, Profitt BF, Wysocki CJ, Gilbert AN, Cotman CW: Life span changes in the verbal categorization of odors. J Gerontol Psychol Sci 1993;48:P49–P53.
  4. Ship JA, Pearson JD, Cruise LJ, Brant LJ, Metter EJ: Longitudinal changes in smell identification. J Gerontol Med Sci 1996;51:M86–M91.
  5. Devanand DP, Michaels-Marston KS, Liu X, et al: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer’s disease at follow-up. Am J Psychiatry 2000;157:1399–1405.
  6. Larsson M, Nilsson LG, Olofsson JK, Nordin S: Demographic and cognitive predictors of cued odor identification: evidence from a population-based study. Chem Senses 2004;29:547–554.
  7. Finkel D, Pedersen NL, Larsson M: Olfactory functioning and cognitive abilities: a twin study. J Gerontol Psychol Sci 2001;56B:P226–P233.
  8. Nordin S, Murphy C: Impaired sensory and cognitive olfactory function in questionable Alzheimer’s disease. Neuropsychology 1996;10:113–119.

    External Resources

  9. Peters JM, Hummell T, Kratzsch T, Lostsch J, Skarke C, Frolich L: Olfactory function in mild cognitive impairment and Alzheimer’s disease: an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry 2003;160:1995–2002.
  10. Wang Q-S, Tian L, Huang Y-L, Qin S, He L-Q, Zhou J-N: Olfactory identification and apolipoprotein E υ4 in mild cognitive impairment. Brain Res 2002;951:77–81.
  11. Royet JP, Croisile JB, Williamson-Vasta R, Hibert O, Serclerat D, Guerin J: Rating of different olfactory judgments in Alzheimer’s disease. Chem Senses 2001;26:409–417.
  12. Serby M, Larson P, Kalkstein D: The nature and course of olfactory deficits in Alzheimer’s disease. Am J Psychiatry 1991;418:357–360.

    External Resources

  13. Mesholam RI, Moberg PJ, Mahr RN, Doty RL: Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch Neurol 1998;55:84–90.
  14. Double KL, Rowe DB, Hayes M, et al: Identifying the pattern of olfactory deficits in Parkinson’s disease using the Brief Smell Identification Test. Arch Neurol 2003;60:545–549.
  15. Hudry J, Thobois S, Broussolle E, Adeleine P, Royet JP: Evidence for deficiencies in perceptual and semantic olfactory processes in Parkinson’s disease. Chem Senses 2003;28:537–543.
  16. Nordin S, Paulsen JS, Murphy C: Sensory-and memory-mediated olfactory dysfunction in Huntington’s disease. J Int Neuropsychol Soc 1995;1:281–290.
  17. Graves AB, Bowen JD, Rajaram L, et al: Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E υ4 status. Neurology 1999;53:1480–1487.
  18. Royall DR, Chiodo LK, Polk MJ, Jaramillo CJ: Severe dysosmia is specifically associated with Alzheimer-like memory deficits in nondemented elderly retirees. Neuroepidemiology 2002;21:68–73.
  19. Swan GE, Carmelli D: Impaired olfaction predicts cognitive decline in nondemented older adults. Neuroepidemiology 2002;21:58–67.
  20. Rogosa D, Brandt D, Zimowski M: A growth curve approach to the measurement of change. Psychol Bull 1982;92:726–748.

    External Resources

  21. Bennett DA, Schneider JA, Buchman AS, Mendes de Leon CF, Bienias JL, Wilson RS: The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 2005;25: 163–175.
  22. Wilson RS, Barnes LL, Bennett DA: Assessment of lifetime participation in cognitively stimulating activities. J Clin Exp Neuropsychol 2003;25:634–642.
  23. Wilson RS, Barnes LL, Krueger KR, Hoganson G, Bienias JL, Bennett DA: Early and late life cognitive activity and cognitive systems in old age. J Int Neuropsychol Soc 2005;11:400–407.
  24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 1984;34:939–944.
  25. Doty RL, Marcus A, Lee WW: Development of the 12-item Cross-Cultural Smell Identification Test (CC-SIT). Laryngoscope 1996;106:353–356.
  26. Doty RL, Frye RE, Agrawal U: Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys 1989;45:381–384.
  27. Smith A: Symbol Digit Modalities Test manual-revised. Los Angeles, Western Psychological Services, 1982.
  28. Ekstrom RB, French JW, Harman HH, Kermen D: Manual for kit of factor-referenced cognitive tests. Princeton, Educational Testing Service, 1976.
  29. Trenerry MR, Crosson B, DeBoe J, Leber WR: The Stroop Neuropsychological Screening Test. Odessa, Psychological Assessment Resources, 1989.
  30. Morris J, Heyman A, Mohs R, et al: The consortium to establish a registry for Alzheimer’s disease (CERAD). I. Clinical and neuropsychological assessment of Alzheimer’s disease. Neurology 1989;39:1159–1165.
  31. Albert M, Smith L, Scherr P, Taylor J, Evans D, Funkenstein H: Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer’s disease. Int J Neurosci 1991;57:167–178.
  32. Wilson RS, Beckett LA, Barnes LL, et al: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002;17:179–193.
  33. Wechsler D: Wechsler Memory Scale-Revised manual. San Antonio, Psychological Corporation, 1987.
  34. Kaplan EF, Goodglass H, Weintraub S: The Boston Naming Test. Philadelphia, Lea & Febiger, 1983.
  35. Nelson HE: National Adult Reading Test (NART): test manual. Windsor, NFER Nelson, 1982.
  36. Cooper JA, Sager HJ: Incidental and intentional recall in Parkinson’s disease: an account based on diminished attentional resources. J Clin Exp Neuropsychol 1993;15:713–731.
  37. Benton AL, Sivan AB, Hamsher K, Varney NR, Spreen O: Contributions to Neuropsychologial Assessment, ed 2. New York, Oxford University Press, 1994.
  38. Raven JC, Court JH, Raven J: Manual for Raven’s Progressive Matrices and Vocabulary: Standard Progressive Matrices. Oxford, Oxford Psychologists Press, 1992.
  39. Laird N, Ware J: Random-effects models for longitudinal data. Biometrics 1982;38:963–974.
  40. Wilson RS, Gilley DW, Bennett DA, Beckett LA, Evans DA: Person-specific paths of cognitive decline in Alzheimer’s disease and their relation to age. Psychol Aging 2000;15:18–28.
  41. SAS Institute Inc. SAS/STAT® User’s Guide, Version 8. Cary, SAS Institute, 2000.
  42. Ohm TG, Braak H: Olfactory bulb changes in Alzheimer’s disease. Acta Neuropathol 1987;73:365–369.
  43. Tsuboi Y, Wszolek ZK, Graff-Radford NR, Cookson N, Dickson DW: Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein epsilon 4. Neuropathol Appl Neurobiol 2003;29:503–510.
  44. Arnold SE, Hyman BT, Flory J, Damasio AR, van Hoesen GW: The topographical and neuroanaotomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer’s disease. Cereb Cortex 1991;1:103–116.
  45. Braak H, Break E: The human entorphinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res 1992;15:6–31.
  46. van Hoesen GW, Parvizi J, Chu CC: Orbitofrontal cortex pathology in Alzheimer’s disease. Cereb Cortex 2000;10:243–251.
  47. Chu CC, Tranel D, Damasio AR, van Hoesen GW: The autonomic-related cortex: pathology in Alzheimer’s disease. Cereb Cortex 1997;6:530–539.
  48. Alvarez P, Squire LR: Memory consolidation and the medial temporal lobe: a simple network model. Proc Natl Acad Sci USA 1994;91:7041–7045.
  49. Stuss DT, Alexander MP, Shallice T, Picton TW, Binns MA, Macdonald R, Borowiec A, Katz DI: Multiple frontal systems controlling response speed. Neuropsychologia 2005;43:396–417.
  50. Stuss DT, Floden D, Alexander MP, Levine B, Katz D: Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia 2001;39:771–786.
  51. Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS: Anterior cingulate conflict monitoring and adjustments in control. Science 2004;303:1023–1026.
  52. Langenecker SA, Nelson KA, Rao SM: fMRI of healthy older adults during Stroop interference. Neuroimage 2004;21:192–200.
  53. MacDonald AW, Cohen JD, Stenger VA, Carter CS: Dissociating the role of the dorsolateral prefrontal and anterior cingulate cortex in cognitive control. Science 2000;288:1835–1838.
  54. Dulay MF, Murphy C: Olfactory activity and cognitive function converge in older adulthood: support for the common cause hypothesis. Psychol Aging 2002;17:392–404.
  55. Wilson DA, Stevenson RJ: The fundamental role of memory in olfactory perception. Trends Neurosci 2003;26:243–247.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50